1.Griffiss, JM. Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiological model. Rev Infect Dis 1982; 4: 159–72.
2.Broome, CV. The carrier state: Neisseria meningitidis. J Antimicrob Chemother 1986; 18 (suppl. A): 25–34.
3.Cartwright, KAV, Stuart, JM, Jones, DM, Noah, ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987; 99: 591–601.
4.DeWals, P, Gilquin, C, DeMaeyer, S, et al. Longitudinal study of asymptomatic carriage in two Belgian populations of school-children. J Infect 1983; 6: 147–56.
5.Olcén, P, Kjellander, J, Danielsson, D, Lindquist, BL. Epidemiology of Neisseria meningitidis: prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand J Infect Dis 1981; 13: 105–9.
6.Stuart, JM, Cartwright, KAV, Robinson, PM, Noah, ND. Effect of smoking on meningococcal carriage. Lancet 1989; ii: 723–5.
7.Beam, WE Jr, Newberg, NR, Devine, LF, Pierce, WE, Davies, JA. The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population. J Infect Dis 1971; 124: 39–46.
8.Brundage, JF, Zollinger, WD. Evolution of meningococcal disease epidemiology in the US army. In: Vedros, NA, ed. Evolution of meningococcal disease. vol. I. Boca Raton: CRC Press Inc, 1987: 5–25.
9.Holten, E, Vaage, L. Carriers of meningococci among Norwegian naval recruits. Scand J Infect Dis 1971; 3: 135–40.
10.Caugant, DA, Bøvre, K, Gaustad, P, et al. Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen Microbiol 1986; 132: 641–52.
11.Sandven, P, Solberg, O, Ødegaard, K, Myhre, G. Improved medium for the transportation of gonococcal specimens. Acta Path Microbiol Immunol Scand 1982; 90 (sect. B): 73–7.
12.Selander, RK, Caugant, DA, Ochman, H, Musser, JM, Gilmour, MN, Whittam, TS. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol 1986; 51: 873–84.
13.Caugant, DA, Mocca, LF, Frasch, CE, Frøholm, LO, Zollinger, WD, Selander, RK. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol 1987; 169: 2781–92.
14.Caugant, DA, Frøholm, LO, Bøvre, K, et al. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci USA 1986; 83: 4927–31.
15.Sneath, PHA, Sokal, RR. Numerical taxonomy: the principles and practice of numerical classification. San Francisco: Freeman WH & Co., 1973.
16.Wedege, E, Høiby, EA, Rosenqvist, E, Frøholm, LO. Serotyping and subtyping of Neisseria meningitidis isolates by coagglutination, dot-blotting and ELISA. J Med Microbiol 1990; 31: 195–201.
17.Harthug, S, Rosenqvist, E, Høiby, EA, Gedde-Dahl, TW, Frøholm, LO. Antibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigen. J Clin Microbiol 1986; 24: 947–53.
18.Rodbard, D, McClean, SW. Automated computer analysis for enzyme-multiplied immunological techniques. Clin Chem 1977; 23: 112–6.
19.Høiby, EA, Rosenqvist, E, Frøholm, LO, et al. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. NIPH Ann (Oslo) 1991; 14: 147–56.
20.Stuart, JM, Cartwright, KAV, Robinson, PM, Noah, ND. Does eradication of meningococcal carriage in household contacts prevent secondary cases of meningococcal disease? Br Med J 1989; 298: 569–70.
21.Cartwright, KAV, Stuart, JM, Robinson, PM. Meningococcal carriage in close contacts of cases. Epidemiol Infect 1991; 106: 133–41.
22.Cooke, RPD, Riordan, T, Jones, DM, Painter, MJ. Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984–7. Br Med J 1989; 298: 555–8.
23.Caugant, DA, Kristiansen, B-E, Frøholm, LO, Bøvre, K, Selander, RK. Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect Immun 1988; 56: 2060–8.
24.Pether, JVS, Lightfoot, NF, Scott, RJD, Morgan, J, Steele-Perkins, AP, Sheard, SC. Carriage of Neisseria meningitidis: investigations in a military establishment. Epidemiol Infect 1988; 101: 21–42.
25.Høiby, EA, Rosenqvist, E, Bjune, G, Closs, O, Frøholm, LO. Serological responses in Norwegian adult volunteers to a meningococcal 15: P1.16 outer membrane vesicle vaccine (Phase II studies). In: Achtman, M, Kohl, P, Marchal, C, Morelli, G, Seiler, A, Thiesen, B, eds. Neisseriae 1990. Berlin: W de Gruyter. 1991: 241–6.
26.Rosenqvist, E, Harthug, S, Frøholm, LO, Høiby, EA, Bøvre, K, Zollinger, WD. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection. J Clin Microbiol 1988; 26: 1543–8.
27.Rosenqvist, E, Høiby, EA, Bjune, G, et al. Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies. NIPH Ann (Oslo) 1991; 14: 169–81.